阐明丹德罗宾在细胞癌治疗中的抗癌潜力
Xing Jia1, Zixuan Chen1, Xingyu Chen2
1Department of Urology, Tongren Hospital Shanghai Jiao Tong University School of Medicine, No.1111 Xian Xia Road, Shanghai, 200336, China.
Naunyn-Schmiedeberg's archives of pharmacology
|January 8, 2025
概括
丹德罗宾是一种天然化合物,通过抑制癌细胞生长,迁移和诱导亡,在治疗细胞癌症 (RCC) 中表现有前途. 这项研究确定了STAT3作为一个关键目标,并通过PI3K/Akt路径揭示了它的机制.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学 是一个学科.
- 自然产品 化学 化学
背景情况:
- 细胞癌 (RCC) 仍然是一个重大的健康问题,耐药性和不良影响限制了目前的治疗方法.
- 天然产品为新型癌症治疗提供了有希望的途径,但它们的特定抗RCC机制往往未被充分探索.
研究的目的:
- 研究天然产品丹德罗宾对细胞癌 (RCC) 的治疗潜力和潜在机制.
- 通过网络药理学和体外验证,确定涉及丹德罗宾抗RCC作用的关键分子标和信号通路.
主要方法:
- 网络药理学被用来预测RCC中的Dendrobine的点,确定STAT3作为一个关键节点.
- 进行了体外测定,包括CCK-8,克隆原性形成,EDU染色,伤口愈合,入侵测定和Hoechst 33342/PI联合染色.
- 西部斑点分析被用来调查丹德罗宾对PI3K/Akt信号通路的影响.
主要成果:
- 登德罗宾显著抑制RCC细胞活力,增殖,迁移和入侵,以剂量依赖的方式.
- 丹德罗宾被证实可以诱导RCC细胞的亡.
- 机理学研究表明,登德罗宾通过抑制p-PI3K,p-Akt和p-Erk表达来向PI3K/Akt信号通路.
结论:
- 登德罗宾通过多种机制表现出强大的抗RCC活性,包括抑制细胞生长和诱导细胞亡.
- PI3K/Akt信号通路是丹德罗宾在RCC中的抗癌作用的关键调解者.
- 登德罗宾代表细胞癌的潜在治疗候选者,需要进一步调查.
相关概念视频
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
201
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
201
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
219
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
219
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147


